Marshall Wace’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$223K Sell
926
-26,169
-97% -$6.32M ﹤0.01% 2285
2025
Q1
$6.6M Buy
27,095
+24,816
+1,089% +$6.04M 0.01% 874
2024
Q4
$749K Buy
+2,279
New +$749K ﹤0.01% 1742
2024
Q1
Sell
-6,300
Closed -$2.03M 2126
2023
Q4
$2.03M Sell
6,300
-119,350
-95% -$38.5M ﹤0.01% 1008
2023
Q3
$45M Buy
125,650
+106,037
+541% +$38M 0.09% 215
2023
Q2
$7.44M Sell
19,613
-13,749
-41% -$5.21M 0.01% 749
2023
Q1
$16M Buy
33,362
+32,767
+5,507% +$15.7M 0.03% 468
2022
Q4
$250K Sell
595
-172,005
-100% -$72.3M ﹤0.01% 2040
2022
Q3
$72M Sell
172,600
-52,169
-23% -$21.8M 0.16% 121
2022
Q2
$111M Sell
224,769
-242,574
-52% -$120M 0.23% 82
2022
Q1
$263M Buy
467,343
+133,973
+40% +$75.5M 0.5% 24
2021
Q4
$252M Sell
333,370
-105,974
-24% -$80.1M 0.47% 30
2021
Q3
$328M Buy
439,344
+4,245
+1% +$3.17M 1.36% 2
2021
Q2
$280M Sell
435,099
-133,819
-24% -$86.2M 1.27% 4
2021
Q1
$325M Buy
568,918
+199,507
+54% +$114M 1.49% 1
2020
Q4
$215M Buy
369,411
+88,844
+32% +$51.8M 1.17% 10
2020
Q3
$145M Buy
280,567
+47,465
+20% +$24.5M 0.93% 12
2020
Q2
$105M Buy
233,102
+120,850
+108% +$54.6M 0.74% 18
2020
Q1
$39.4M Buy
112,252
+111,393
+12,968% +$39M 0.39% 52
2019
Q4
$318K Sell
859
-77,897
-99% -$28.8M ﹤0.01% 1211
2019
Q3
$26.2M Buy
78,756
+57,281
+267% +$19.1M 0.21% 104
2019
Q2
$6.71M Buy
+21,475
New +$6.71M 0.06% 386
2019
Q1
Sell
-9,196
Closed -$2.14M 1703
2018
Q4
$2.14M Sell
9,196
-14,767
-62% -$3.43M 0.02% 701
2018
Q3
$7.5M Buy
23,963
+20,850
+670% +$6.53M 0.06% 366
2018
Q2
$898K Buy
+3,113
New +$898K 0.01% 521
2017
Q3
Sell
-1,114
Closed -$252K 342
2017
Q2
$252K Buy
+1,114
New +$252K 0.01% 282